Lin Health

Lin Health aims to address the significant challenges in chronic pain management by leveraging science and technology. Founded in 2021 and based in the United States, the startup is at the forefront of a paradigm shift in the medical field, targeting the 1 in 5 Americans affected by chronic pain, which incurs a staggering $300B in direct care costs annually. The company's pioneering approach centers on recognizing chronic pain as a standalone diagnosis, with a focus on the brain as its primary cause, as acknowledged by the new diagnostic code - Chronic Primary Pain (ICD-11). While this innovative perspective advances diagnostic capabilities, Lin Health goes a step further by providing a scalable, tech-enabled clinic – a pioneering solution in the US for patients and physicians. Propelled by the latest pain science and proprietary technology, the digital clinic offers a low-risk frontline approach to Chronic Primary Pain, filling a critical gap in the healthcare system. Notably, the startup has garnered support from the healthcare industry, including endorsements from health plans, systems, and providers. Lin Health's recent achievement of securing a Seed Round investment at 01 January 2023, backed by Saban Ventures, underscores the confidence in its disruptive potential. With its commitment to empowering patients to reclaim their lives from chronic pain, the startup stands poised to dominate this emerging sector, embodying a convergence of cutting-edge healthcare, technology, and compassionate care.